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EDITORIAL
Dear Colleagues, 
It would be improper if this first edition of JEMDSA 2020 
neglected to comment on the current COVID-19 pandemic. At 
the time of writing the number of confirmed cases stood at 127 
838 thousand and the number of deaths was 4 717 thousand 
(WHO dashboard, 15.03.2020). This infection will certainly impact 
significantly on global mortality and also, somewhat innocently 
so, on the impending and overdue world economic slowdown 
and probable recession. 
While world attention is focussed on this new and novel viral 
pandemic, the other more entrenched pandemic carries on 
more silently. Thus during the ensuing 12 months some 5.1 
million additional human deaths will be attributed to diabetes, 
roughly one death every seven seconds (IDF Report, 2016). Many 
of these deaths will be related to cardiovascular events. In South 
Africa alone, as many as 210 deaths each day are accounted for 
by a cardiac aetiology (Heart and Stroke Foundation SA, 2017). 
So how are South African clinicians inadvertently contributing 
to this NCD pandemic? Retrospective data from two tertiary 
academic institutions give some clear insights to this question. 
Firstly Naidoo S, et al. indicate that in a cohort of 200 diabetic 
patients with a median HbAic of 8.3% only 26.5% and 12.5% 
of patients achieved ideal LDL cholesterol and composite lipid 
targets, respectively. In the second study Bulbulia S, et al. in a 
cohort of 321 diabetic patients offer much the same results – the 
mean HbAic level was 9.5% and ideal targets were only achieved 
in 15.3% (HbAic), 22.6% (LDL cholesterol), 25% (blood pressure) 
and 11% (waist circumference) of patients, respectively. It would 
seem that “new” and “smarter” strategies are needed to address 
these identified deficiencies in treatment. A third study by 
Mhishi SB, et al. also identifies a practical and real world deficit 
in diabetes care – most patients in their cohort were unable 
to assess glucose levels accurately utilising photometric strips 
suggesting that self-monitoring without access to a glucose 
meter may not only be inaccurate but also unsafe. 
Most journals avoid publishing reviews and case-studies unless 
these offer unique and/or paradigm shifting options in enhancing 
clinical practice. Schellack N, et al. offer a very useful review on 
how clinicians should interpret thyroid function tests. As thyroid 
disease is common and thyroid hormone replacement therapy a 
frequent necessity, better insights into the complex interactions 
between TSH, FT4 and FT3 in the absence and presence of T4 
and/or T3 replacement, is welcomed and needed. A rational and 
compelling review of the established, old versus possible, new 
TSH paradigm is presented. The final submission by Coetzee A, 
et al. highlights a unique lesson of chronic/recurrent virilisation 
in a female patient who underwent both hysterectomy and 
bilateral oophorectomy. A definitive diagnosis in such patients is 
often elusive as it is intriguing and alludes to the wisdom often 
expressed, that the practice of medicine is indeed a humbling 
experience.
Happy reading, wash your hands, wear your masks but above all, 
re-strategise on how you will endeavour to improve metabolic 
control in your patients with diabetes.  
Jeff Wing
